Vectiopep

📍 Tartu, Estonia🗓 Founded 2022👥 6 employees💰 Last funded Feb 2024
Biotechnology Research🌐 vectiopep.ee
Website LinkedIn
Vectiopep is developing peptide-based nucleic acid delivery technology. Combined with the new generation mRNA therapeutics, we empower the bodys immune system to fight cancer. Vectiopep is a privately-held biotechnology company, founded by a group of researchers who have more than 10 years of expertise in developing and optimizing delivery technologies for nucleic acids..
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Vectiopep?
Vectiopep has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Vectiopep last raise funding?
The most recent investment in Vectiopep recorded on gritt.io was in February 2024.
When was Vectiopep founded?
Vectiopep was founded in 2022.
What industry is Vectiopep in?
Vectiopep operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vectiopep based?
Vectiopep is headquartered in Tartu, Estonia.